Highmark attributed the improvement, which is up from $534 million in the first half of 2017, to strong performance in its commercial and government health plan units, as well as operational improvements at AHN. AHN ended the second quarter of 2018 with operating income of $22.3 million, up from the $16.4 million the health system recorded in the same period a year prior.
As a whole, Highmark reported an operating gain of $502 million, which was comparable to the same period in 2017. Its health plan remains the largest in Pennsylvania, with 4.6 million members as of June 30.
“As we’ve stated before, Highmark Health has a holistic capital plan and strategy and a diversified business operating model that enables us to continue to invest in Allegheny Health Network to advance our path to value-based care,” David L. Holmberg, Highmark’s president and CEO, said in a prepared statement.
More articles on healthcare finance:
Investors cash out of HCA as stock hits record high
Michigan hospital blames ‘aggressive, direct competitor’ for financial troubles
Houston hospital’s heart transplant program to lose Medicare funding
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
